| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papillomavirus Vaccines | 16 | 2024 | 71 | 4.220 |
Why?
|
| Vaccination | 22 | 2024 | 213 | 4.150 |
Why?
|
| Pediatrics | 24 | 2018 | 116 | 3.120 |
Why?
|
| Meningococcal Vaccines | 8 | 2020 | 13 | 2.460 |
Why?
|
| Parents | 11 | 2023 | 142 | 2.410 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 7 | 2020 | 20 | 2.310 |
Why?
|
| Immunization | 12 | 2023 | 133 | 2.220 |
Why?
|
| Pediatric Obesity | 5 | 2025 | 79 | 1.550 |
Why?
|
| Child | 39 | 2025 | 2327 | 1.530 |
Why?
|
| Practice Patterns, Physicians' | 10 | 2011 | 177 | 1.450 |
Why?
|
| Patient Acceptance of Health Care | 6 | 2024 | 104 | 1.350 |
Why?
|
| Papillomavirus Infections | 7 | 2024 | 156 | 1.210 |
Why?
|
| Internship and Residency | 13 | 2008 | 263 | 1.160 |
Why?
|
| Rural Population | 5 | 2025 | 137 | 1.120 |
Why?
|
| Adolescent | 26 | 2024 | 3223 | 1.100 |
Why?
|
| Immunization Schedule | 8 | 2020 | 20 | 1.090 |
Why?
|
| Immunization Programs | 5 | 2011 | 20 | 1.070 |
Why?
|
| Humans | 81 | 2025 | 28998 | 1.040 |
Why?
|
| Physician-Patient Relations | 5 | 2015 | 119 | 1.000 |
Why?
|
| Continuity of Patient Care | 7 | 2008 | 33 | 1.000 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2024 | 310 | 0.960 |
Why?
|
| South Carolina | 19 | 2018 | 27 | 0.950 |
Why?
|
| Primary Health Care | 10 | 2024 | 169 | 0.940 |
Why?
|
| Poverty | 3 | 2015 | 90 | 0.860 |
Why?
|
| Vaccines | 3 | 2022 | 37 | 0.860 |
Why?
|
| United States | 22 | 2022 | 2247 | 0.850 |
Why?
|
| Overweight | 2 | 2022 | 114 | 0.790 |
Why?
|
| Male | 38 | 2025 | 13983 | 0.770 |
Why?
|
| Infant | 24 | 2011 | 1049 | 0.770 |
Why?
|
| Child, Preschool | 25 | 2014 | 1196 | 0.770 |
Why?
|
| Female | 38 | 2025 | 15690 | 0.750 |
Why?
|
| Reminder Systems | 2 | 2018 | 13 | 0.640 |
Why?
|
| Diphtheria | 2 | 2015 | 6 | 0.600 |
Why?
|
| Tetanus | 2 | 2015 | 7 | 0.600 |
Why?
|
| Whooping Cough | 2 | 2015 | 17 | 0.600 |
Why?
|
| Influenza Vaccines | 3 | 2018 | 55 | 0.580 |
Why?
|
| Appointments and Schedules | 2 | 2018 | 10 | 0.580 |
Why?
|
| Language | 2 | 2016 | 66 | 0.580 |
Why?
|
| Clinical Medicine | 2 | 2008 | 6 | 0.570 |
Why?
|
| Information Services | 2 | 2008 | 8 | 0.570 |
Why?
|
| Psychology, Adolescent | 1 | 2018 | 14 | 0.560 |
Why?
|
| Child Abuse | 2 | 2016 | 93 | 0.550 |
Why?
|
| Practice Guidelines as Topic | 4 | 2014 | 249 | 0.540 |
Why?
|
| Text Messaging | 1 | 2018 | 24 | 0.540 |
Why?
|
| Body Weight | 3 | 2024 | 253 | 0.530 |
Why?
|
| Communication Barriers | 2 | 2015 | 19 | 0.520 |
Why?
|
| Health Status Disparities | 2 | 2014 | 66 | 0.490 |
Why?
|
| Craniocerebral Trauma | 1 | 2016 | 27 | 0.490 |
Why?
|
| Body Mass Index | 5 | 2025 | 415 | 0.480 |
Why?
|
| Meningococcal Infections | 1 | 2015 | 3 | 0.480 |
Why?
|
| Obesity | 4 | 2022 | 702 | 0.470 |
Why?
|
| Periodicals as Topic | 1 | 2016 | 53 | 0.470 |
Why?
|
| Translating | 1 | 2015 | 14 | 0.470 |
Why?
|
| Sentinel Surveillance | 2 | 2014 | 5 | 0.460 |
Why?
|
| Surveys and Questionnaires | 8 | 2020 | 1011 | 0.440 |
Why?
|
| Oklahoma | 5 | 2018 | 1058 | 0.430 |
Why?
|
| Quality Indicators, Health Care | 3 | 2011 | 54 | 0.430 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 121 | 0.380 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 305 | 0.380 |
Why?
|
| Child Welfare | 4 | 2021 | 43 | 0.380 |
Why?
|
| Prevalence | 6 | 2016 | 521 | 0.380 |
Why?
|
| Guideline Adherence | 2 | 2011 | 97 | 0.370 |
Why?
|
| Cross-Sectional Studies | 9 | 2022 | 1004 | 0.360 |
Why?
|
| Patient-Centered Care | 1 | 2011 | 38 | 0.340 |
Why?
|
| Data Collection | 3 | 2019 | 109 | 0.330 |
Why?
|
| Health Surveys | 3 | 2015 | 88 | 0.330 |
Why?
|
| Health Records, Personal | 1 | 2010 | 4 | 0.320 |
Why?
|
| Outpatient Clinics, Hospital | 3 | 2018 | 10 | 0.320 |
Why?
|
| Capacity Building | 2 | 2021 | 9 | 0.320 |
Why?
|
| Quality Improvement | 3 | 2018 | 127 | 0.300 |
Why?
|
| Ambulatory Care | 3 | 2007 | 63 | 0.290 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2008 | 4 | 0.290 |
Why?
|
| Infant Equipment | 1 | 2008 | 1 | 0.290 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 221 | 0.280 |
Why?
|
| Hepatitis B Vaccines | 1 | 2008 | 4 | 0.280 |
Why?
|
| Hepatitis B | 1 | 2008 | 14 | 0.280 |
Why?
|
| Workload | 1 | 2008 | 44 | 0.270 |
Why?
|
| Logistic Models | 6 | 2014 | 415 | 0.270 |
Why?
|
| Population Surveillance | 1 | 2008 | 87 | 0.270 |
Why?
|
| Indians, North American | 3 | 2021 | 544 | 0.270 |
Why?
|
| Infant, Newborn | 8 | 2008 | 924 | 0.260 |
Why?
|
| Health Personnel | 2 | 2018 | 99 | 0.260 |
Why?
|
| Focus Groups | 2 | 2023 | 104 | 0.230 |
Why?
|
| Family Therapy | 1 | 2025 | 13 | 0.220 |
Why?
|
| Behavior Therapy | 1 | 2025 | 30 | 0.220 |
Why?
|
| Patient Care | 1 | 2004 | 14 | 0.210 |
Why?
|
| Cost Savings | 1 | 2004 | 20 | 0.210 |
Why?
|
| Body Height | 1 | 2024 | 58 | 0.200 |
Why?
|
| Otitis Media | 2 | 1996 | 37 | 0.200 |
Why?
|
| Socioeconomic Factors | 5 | 2014 | 264 | 0.200 |
Why?
|
| Health Care Surveys | 3 | 2013 | 69 | 0.200 |
Why?
|
| Complementary Therapies | 1 | 2003 | 15 | 0.200 |
Why?
|
| Telemedicine | 2 | 2025 | 214 | 0.190 |
Why?
|
| Emergency Service, Hospital | 1 | 2004 | 123 | 0.190 |
Why?
|
| Hypercholesterolemia | 3 | 1992 | 21 | 0.190 |
Why?
|
| Private Practice | 2 | 2001 | 10 | 0.190 |
Why?
|
| Qualitative Research | 1 | 2023 | 206 | 0.180 |
Why?
|
| Office Visits | 3 | 2011 | 11 | 0.180 |
Why?
|
| Communication | 2 | 2020 | 184 | 0.170 |
Why?
|
| African Americans | 3 | 2014 | 353 | 0.170 |
Why?
|
| Retrospective Studies | 6 | 2011 | 2644 | 0.170 |
Why?
|
| House Calls | 2 | 2015 | 16 | 0.160 |
Why?
|
| Time Factors | 4 | 2011 | 1619 | 0.160 |
Why?
|
| Adult | 7 | 2018 | 8048 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2024 | 413 | 0.160 |
Why?
|
| Professional Practice | 2 | 2019 | 11 | 0.150 |
Why?
|
| Physicians, Family | 1 | 1999 | 14 | 0.150 |
Why?
|
| Hospitals, Pediatric | 1 | 1998 | 32 | 0.140 |
Why?
|
| Research Support as Topic | 1 | 2018 | 8 | 0.140 |
Why?
|
| Feedback, Psychological | 1 | 2018 | 4 | 0.140 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 303 | 0.140 |
Why?
|
| Professional-Patient Relations | 1 | 2018 | 29 | 0.140 |
Why?
|
| Age Factors | 3 | 2018 | 740 | 0.140 |
Why?
|
| Child Health | 1 | 2018 | 18 | 0.140 |
Why?
|
| Medically Underserved Area | 1 | 2018 | 19 | 0.140 |
Why?
|
| Rural Health Services | 1 | 2018 | 26 | 0.140 |
Why?
|
| Oregon | 3 | 2023 | 11 | 0.140 |
Why?
|
| Counseling | 4 | 1996 | 61 | 0.130 |
Why?
|
| Clinical Competence | 6 | 1999 | 245 | 0.130 |
Why?
|
| Mothers | 2 | 2015 | 126 | 0.130 |
Why?
|
| Evidence-Based Medicine | 2 | 2008 | 148 | 0.130 |
Why?
|
| Fellowships and Scholarships | 2 | 2007 | 42 | 0.130 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1996 | 3 | 0.130 |
Why?
|
| Education, Medical, Graduate | 2 | 2007 | 119 | 0.130 |
Why?
|
| Spain | 1 | 2016 | 19 | 0.120 |
Why?
|
| Common Cold | 1 | 1996 | 2 | 0.120 |
Why?
|
| Nasal Decongestants | 1 | 1996 | 3 | 0.120 |
Why?
|
| Eustachian Tube | 1 | 1996 | 4 | 0.120 |
Why?
|
| Phenylephrine | 1 | 1996 | 14 | 0.120 |
Why?
|
| Sex Factors | 1 | 2018 | 470 | 0.120 |
Why?
|
| Health Services Needs and Demand | 1 | 1996 | 40 | 0.120 |
Why?
|
| Linear Models | 2 | 2008 | 204 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 78 | 0.120 |
Why?
|
| Attitude of Health Personnel | 4 | 2007 | 154 | 0.120 |
Why?
|
| Utilization Review | 1 | 2015 | 10 | 0.120 |
Why?
|
| Multilingualism | 1 | 2015 | 17 | 0.120 |
Why?
|
| Age Distribution | 2 | 2008 | 75 | 0.120 |
Why?
|
| Minnesota | 1 | 2015 | 43 | 0.120 |
Why?
|
| Terminology as Topic | 1 | 2016 | 64 | 0.120 |
Why?
|
| Ambulatory Care Facilities | 1 | 2015 | 55 | 0.120 |
Why?
|
| Incidence | 2 | 2016 | 573 | 0.110 |
Why?
|
| Adolescent Medicine | 1 | 1995 | 4 | 0.110 |
Why?
|
| Child Protective Services | 1 | 2015 | 3 | 0.110 |
Why?
|
| Education, Medical, Continuing | 1 | 1995 | 35 | 0.110 |
Why?
|
| School Health Services | 1 | 2015 | 37 | 0.110 |
Why?
|
| Feasibility Studies | 3 | 2025 | 225 | 0.110 |
Why?
|
| Cefuroxime | 2 | 1992 | 6 | 0.110 |
Why?
|
| Nutrition Surveys | 1 | 2014 | 32 | 0.110 |
Why?
|
| Sex Distribution | 1 | 2014 | 78 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2015 | 271 | 0.110 |
Why?
|
| Diphtheria-Tetanus Vaccine | 1 | 2013 | 2 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2014 | 97 | 0.100 |
Why?
|
| Attitude | 1 | 2013 | 45 | 0.100 |
Why?
|
| Perception | 1 | 2013 | 91 | 0.100 |
Why?
|
| Middle Aged | 5 | 2015 | 7428 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 2013 | 162 | 0.090 |
Why?
|
| Food Assistance | 1 | 2012 | 13 | 0.090 |
Why?
|
| Typhoid Fever | 1 | 2011 | 1 | 0.090 |
Why?
|
| Smallpox | 1 | 2011 | 7 | 0.090 |
Why?
|
| History, 17th Century | 1 | 2011 | 8 | 0.090 |
Why?
|
| History, 18th Century | 1 | 2011 | 13 | 0.090 |
Why?
|
| Poliomyelitis | 1 | 2011 | 7 | 0.090 |
Why?
|
| Pandemics | 2 | 2024 | 205 | 0.090 |
Why?
|
| History, 19th Century | 1 | 2011 | 37 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2011 | 50 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2011 | 85 | 0.090 |
Why?
|
| Hospitals, University | 2 | 2004 | 28 | 0.090 |
Why?
|
| Forms and Records Control | 1 | 2011 | 6 | 0.080 |
Why?
|
| Cefaclor | 1 | 1990 | 1 | 0.080 |
Why?
|
| Clavulanic Acids | 1 | 1990 | 3 | 0.080 |
Why?
|
| Amoxicillin | 1 | 1990 | 7 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2011 | 99 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2011 | 95 | 0.080 |
Why?
|
| Teaching | 1 | 1991 | 84 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 1990 | 210 | 0.080 |
Why?
|
| Health Behavior | 1 | 2011 | 159 | 0.080 |
Why?
|
| Curriculum | 3 | 2007 | 307 | 0.070 |
Why?
|
| Safety | 2 | 2021 | 33 | 0.070 |
Why?
|
| Infant Welfare | 1 | 2008 | 3 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 2 | 2019 | 50 | 0.070 |
Why?
|
| Neoplasms | 1 | 2018 | 879 | 0.070 |
Why?
|
| Headache | 1 | 2008 | 35 | 0.070 |
Why?
|
| Family Practice | 2 | 2019 | 47 | 0.070 |
Why?
|
| Risk Factors | 4 | 2008 | 2134 | 0.070 |
Why?
|
| Social Class | 1 | 2008 | 82 | 0.070 |
Why?
|
| Attitude to Health | 2 | 2002 | 91 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2007 | 84 | 0.060 |
Why?
|
| Faculty, Medical | 1 | 2007 | 60 | 0.060 |
Why?
|
| Community Networks | 1 | 2006 | 11 | 0.060 |
Why?
|
| Child Health Services | 2 | 2019 | 9 | 0.060 |
Why?
|
| Double-Blind Method | 4 | 2003 | 426 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 788 | 0.060 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2005 | 65 | 0.060 |
Why?
|
| Internet | 1 | 2005 | 128 | 0.050 |
Why?
|
| Accreditation | 1 | 2004 | 37 | 0.050 |
Why?
|
| Internal Medicine | 2 | 1996 | 30 | 0.050 |
Why?
|
| Models, Econometric | 1 | 2004 | 6 | 0.050 |
Why?
|
| Chlorobutanol | 1 | 2003 | 1 | 0.050 |
Why?
|
| Dioctyl Sulfosuccinic Acid | 1 | 2003 | 1 | 0.050 |
Why?
|
| Ethanolamines | 1 | 2003 | 2 | 0.050 |
Why?
|
| Cerumen | 1 | 2003 | 2 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2003 | 20 | 0.050 |
Why?
|
| Research Design | 2 | 2021 | 188 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2003 | 45 | 0.050 |
Why?
|
| Caregivers | 1 | 2025 | 120 | 0.050 |
Why?
|
| Bacterial Vaccines | 1 | 2023 | 30 | 0.050 |
Why?
|
| Consumer Behavior | 1 | 2002 | 15 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2023 | 67 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2003 | 358 | 0.050 |
Why?
|
| Health Services Research | 1 | 2001 | 45 | 0.040 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 2001 | 1 | 0.040 |
Why?
|
| Registries | 1 | 2023 | 398 | 0.040 |
Why?
|
| Peptides | 1 | 2003 | 297 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 139 | 0.040 |
Why?
|
| Program Evaluation | 2 | 2015 | 176 | 0.040 |
Why?
|
| Environmental Exposure | 2 | 2018 | 53 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2000 | 80 | 0.040 |
Why?
|
| Lactose | 1 | 2000 | 7 | 0.040 |
Why?
|
| Infant Food | 1 | 2000 | 12 | 0.040 |
Why?
|
| Urogenital Neoplasms | 1 | 2019 | 1 | 0.040 |
Why?
|
| Rural Health | 1 | 2019 | 16 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2019 | 127 | 0.040 |
Why?
|
| Academies and Institutes | 1 | 1998 | 17 | 0.040 |
Why?
|
| Patient Compliance | 1 | 1999 | 77 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2018 | 12 | 0.030 |
Why?
|
| Environmental Health | 1 | 2018 | 11 | 0.030 |
Why?
|
| Health Education | 1 | 1999 | 76 | 0.030 |
Why?
|
| Vaccination Coverage | 1 | 2018 | 14 | 0.030 |
Why?
|
| Educational Measurement | 2 | 1989 | 139 | 0.030 |
Why?
|
| Lead | 1 | 1997 | 10 | 0.030 |
Why?
|
| Influenza A virus | 1 | 1997 | 40 | 0.030 |
Why?
|
| Motivation | 1 | 1999 | 217 | 0.030 |
Why?
|
| Prenatal Care | 1 | 1997 | 47 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 1996 | 13 | 0.030 |
Why?
|
| Nutritional Sciences | 1 | 1996 | 13 | 0.030 |
Why?
|
| Cardiology Service, Hospital | 1 | 1996 | 6 | 0.030 |
Why?
|
| Random Allocation | 1 | 1996 | 152 | 0.030 |
Why?
|
| Pressure | 1 | 1996 | 91 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 1996 | 92 | 0.030 |
Why?
|
| Education, Nonprofessional | 1 | 2015 | 5 | 0.030 |
Why?
|
| Community Health Services | 1 | 2015 | 34 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2015 | 68 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 1997 | 393 | 0.030 |
Why?
|
| Parenting | 1 | 2015 | 57 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 119 | 0.030 |
Why?
|
| Prospective Studies | 1 | 1996 | 1283 | 0.020 |
Why?
|
| Cefadroxil | 1 | 1992 | 1 | 0.020 |
Why?
|
| Skin Diseases, Infectious | 1 | 1992 | 4 | 0.020 |
Why?
|
| Prodrugs | 1 | 1992 | 31 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2011 | 66 | 0.020 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 1990 | 3 | 0.020 |
Why?
|
| Acoustic Impedance Tests | 1 | 1990 | 5 | 0.020 |
Why?
|
| Life Style | 1 | 2011 | 91 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 44 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2010 | 25 | 0.020 |
Why?
|
| Weight Loss | 1 | 2011 | 83 | 0.020 |
Why?
|
| Comorbidity | 1 | 2011 | 261 | 0.020 |
Why?
|
| Pneumococcal Infections | 1 | 1990 | 24 | 0.020 |
Why?
|
| Acute Disease | 1 | 1990 | 156 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 1990 | 19 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1990 | 225 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1990 | 191 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1990 | 62 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 1996 | 2427 | 0.020 |
Why?
|
| Sepsis | 1 | 1990 | 87 | 0.020 |
Why?
|
| Cholesterol | 1 | 1991 | 204 | 0.020 |
Why?
|
| Myocardium | 1 | 1990 | 197 | 0.020 |
Why?
|
| Health Policy | 2 | 2001 | 63 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2008 | 16 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 1990 | 144 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2008 | 12 | 0.020 |
Why?
|
| Ibuprofen | 1 | 2008 | 18 | 0.020 |
Why?
|
| Analgesics | 1 | 2008 | 39 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 79 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 2842 | 0.020 |
Why?
|
| Program Development | 1 | 2007 | 88 | 0.020 |
Why?
|
| Minority Groups | 1 | 2006 | 76 | 0.010 |
Why?
|
| Computer-Assisted Instruction | 1 | 2005 | 33 | 0.010 |
Why?
|
| Ear Canal | 1 | 2003 | 7 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2003 | 51 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2003 | 68 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2003 | 28 | 0.010 |
Why?
|
| Tympanic Membrane | 1 | 2003 | 39 | 0.010 |
Why?
|
| Mass Screening | 1 | 2003 | 159 | 0.010 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 2001 | 2 | 0.010 |
Why?
|
| Medical Records | 1 | 2001 | 52 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 2000 | 13 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2000 | 36 | 0.010 |
Why?
|
| Creatinine | 1 | 2000 | 60 | 0.010 |
Why?
|
| Anthropometry | 1 | 2000 | 94 | 0.010 |
Why?
|
| Vaccines, Attenuated | 1 | 1997 | 8 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1997 | 14 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1997 | 81 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 1997 | 25 | 0.010 |
Why?
|
| Health Care Costs | 1 | 1997 | 51 | 0.010 |
Why?
|
| Maternal Exposure | 1 | 1997 | 29 | 0.010 |
Why?
|
| Aged | 2 | 1996 | 5608 | 0.010 |
Why?
|
| Mid-Atlantic Region | 1 | 1992 | 1 | 0.010 |
Why?
|
| Southeastern United States | 1 | 1992 | 5 | 0.010 |
Why?
|
| Suspensions | 1 | 1992 | 7 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1992 | 47 | 0.010 |
Why?
|
| Pregnancy | 1 | 1997 | 1260 | 0.010 |
Why?
|
| Group Practice | 1 | 1991 | 3 | 0.010 |
Why?
|
| Computers | 1 | 1991 | 31 | 0.010 |
Why?
|
| Cues | 1 | 1991 | 41 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1991 | 116 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 64 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1990 | 29 | 0.000 |
Why?
|
| Species Specificity | 1 | 1990 | 196 | 0.000 |
Why?
|
| Survival Rate | 1 | 1990 | 433 | 0.000 |
Why?
|
| Length of Stay | 1 | 1990 | 246 | 0.000 |
Why?
|
| Prognosis | 1 | 1989 | 812 | 0.000 |
Why?
|
| Rats | 1 | 1990 | 1592 | 0.000 |
Why?
|
| Animals | 1 | 1990 | 10715 | 0.000 |
Why?
|